Cargando…
BclX(L) (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury
Autores principales: | Marola, Olivia J., Yablonski, Sarah E. R., Shrager, Peter G., Nickells, Robert W., Libby, Richard T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307748/ https://www.ncbi.nlm.nih.gov/pubmed/35869049 http://dx.doi.org/10.1038/s41420-022-01111-4 |
Ejemplares similares
-
DDIT3 (CHOP) contributes to retinal ganglion cell somal loss but not axonal degeneration in DBA/2J mice
por: Marola, Olivia J., et al.
Publicado: (2019) -
Transcriptional control of retinal ganglion cell death after axonal injury
por: Syc-Mazurek, Stephanie B., et al.
Publicado: (2022) -
Together JUN and DDIT3 (CHOP) control retinal ganglion cell death after axonal injury
por: Syc-Mazurek, Stephanie B., et al.
Publicado: (2017) -
Factors Associated with Vascular Changes at the Level of Retinal Ganglion Cell Axon versus Soma/Dendrite in Glaucoma Patients
por: Oh, Si-Eun, et al.
Publicado: (2023) -
Development and Degeneration of Retinal Ganglion Cell Axons in Xenopus tropicalis
por: Choi, Boyoon, et al.
Publicado: (2022)